Markets:

Overview

News

Currencies

International

Treasuries

Lipocine Inc. - Common Stock (NQ:LPCN)

2.370 -0.190 (-7.42%)

Streaming Delayed Price Updated: 1:48 PM EDT, Apr 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lipocine Inc. - Common Stock

< Previous 1 2 3 Next >

20 Stocks Moving in Tuesday's Pre-Market Session ↗

March 29, 2022

Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) rose 40.1% to $21.00 in pre-market trading following announcement of collaboration with Sanofi (NASDAQ: SNY). Guardforce AI Co.,...

Via Benzinga

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More ↗

March 27, 2022

Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates ↗

March 02, 2022

The Food and Drug Administration approval calendar was light in February. Nevertheless, the month saw regulatory nods accorded to some breakthrough therapies. Agios...

Via Benzinga

The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales ↗

January 06, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Illumina Announces Co-Development Partnership With SomaScan For Accelerating...

Via Benzinga

5 Penny Stocks Insiders Are Buying ↗

November 19, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 19, 2021

Gainers Sesen Bio (NASDAQ:SESN) stock mo...

Via Benzinga

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

18 Stocks Moving in Tuesday's Pre-Market Session ↗

October 19, 2021

Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) rose 26.1% to $2.03 in pre-market trading after surging 18% on Monday. Kaival Brands Innovations recently announced...

Via Benzinga

Lipocine, Antares Ink Licensing Pact For Testosterone Replacement Therapy In US ↗

October 18, 2021

Lipocine Inc (NASDAQ: LPCN) has entered into an exclusive licensing agreement with Antares Pharma Inc (NASDAQ: ATRS) to commercialize Tlando in the U.S....

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 28, 2021

Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares increased by 70.28% to $9.11 during Tuesday's pre-market session. The company's market cap stands at $24.5...

Via Benzinga

Lipocine Meets Resolution Regulatory Endpoint In Mid-Stage NASH Trial ↗

August 25, 2021

Lipocine Inc (NASDAQ: LPCN) has announced topline 36-week results from its Phase 2 proof of concept LiFT study investigating LPCN 1144 in Non-Alcoholic...

Via Benzinga

The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug ↗

August 25, 2021

ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs ↗

October 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results ↗

October 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗

October 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...

Via Benzinga

The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs ↗

July 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,...

Via Benzinga

Topics Product Recall

22 Stocks Moving in Thursday's Pre-Market Session ↗

July 15, 2021

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares rose 63.2% to $8.03 in pre-market trading after jumping around 8% on Wednesday. Verb Technology Company, Inc. (...

Via Benzinga

Lipocine Stock Jumps On Litigation Settlement With Clarus Therapeutics ↗

July 15, 2021

Lipocine Inc (NASDAQ: LPCN) has entered into a settlement and license agreement with Clarus Therapeutics to resolve claims in the ongoing intellectual...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2021 ↗

June 24, 2021

Upgrades Zelman upgraded the previous rating for Armstrong World Industries Inc (NYSE:

Via Benzinga

Lipocine To Start Testing Neuro-Steroid Candidate In Postpartum Depression Patients ↗

June 14, 2021

The FDA has signed off Lipocine Inc's (NASDAQ: LPCN) Investigational New Drug Application (IND) to initiate a Phase 2 study to evaluate LPCN 1154 for the...

Via Benzinga

60 Biggest Movers From Yesterday ↗

May 27, 2021

Gainers Lizhi Inc. (NASDAQ: LIZI) shares surged 57.6% to close at $6.84 on Wednesday. Flywire Corporation (NASDAQ: FLYW) gained 46.3% to settle at $35.10 after the company priced...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 26, 2021

Gainers Owens & Minor (NYSE:OMI) shares rose 25.47% to $40.66 during Wednesday's regular session. As of 12:31 EST, this security is trading at a volume of 5.4...

Via Benzinga

Clarus Therapeutics Wins Jatenzo Patent Infringement Case Brought By Lipocine ↗

May 26, 2021

The U.S. District Court for the District of Delaware has granted Clarus Therapeutics' motion for summary judgment against remaining patents in a patent infringement...

Via Benzinga

Topics Intellectual Property

41 Stocks Moving In Wednesday's Mid-Day Session ↗

May 26, 2021

Gainers Asensus Surgical, Inc. (NYSE: ASXC) shares surged 34.4% to $2.7282. HC Wainwright & Co. initiated coverage on Asensus Surgical with a Buy rating and announced a price...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 26, 2021

Gainers Pieris Pharmaceuticals (NASDAQ:PIRS) stock moved upwards by 20.74% to $4.54 during Wednesday's pre-market session. The market value of their outstanding shares...

Via Benzinga

22 Stocks Moving in Wednesday's Pre-Market Session ↗

May 26, 2021

Gainers Nabriva Therapeutics plc (NASDAQ: NBRV) rose 48.8% to $2.20 in pre-market trading. Sinovant Sciences and Nabriva Therapeutics disclosed topline results from Phase 3 trial...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 18, 2021

Gainers Lixte Biotech Holdings (NASDAQ:LIXT

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.